Literature DB >> 26849276

Enigma of painful diabetic neuropathy: can we use the basic science, research outcomes and real-world data to help improve patient care and outcomes?

D V Coppini1.   

Abstract

The pathogenesis of painful diabetic neuropathy (PDN) is very complex and its detailed understanding often beyond the remit of the diabetologist or the diabetes multidisciplinary team. Nonetheless it is a very common and difficult to treat complication of diabetes, with significant co-morbidity and mortality, and some basic understanding may help the health care professional with its day to day management. In this review, we discuss the basic pathological mechanisms of PDN, and its clinical manifestations, and present both scientific and real world data on its management, in an attempt to help improve patient care and outcomes.
© 2016 Diabetes UK.

Entities:  

Mesh:

Year:  2016        PMID: 26849276     DOI: 10.1111/dme.13089

Source DB:  PubMed          Journal:  Diabet Med        ISSN: 0742-3071            Impact factor:   4.359


  10 in total

1.  CELF1 contributes to aberrant alternative splicing patterns in the type 1 diabetic heart.

Authors:  KarryAnne Belanger; Curtis A Nutter; Jin Li; Sadia Tasnim; Peiru Liu; Peng Yu; Muge N Kuyumcu-Martinez
Journal:  Biochem Biophys Res Commun       Date:  2018-08-27       Impact factor: 3.575

2.  Developmentally regulated alternative splicing is perturbed in type 1 diabetic skeletal muscle.

Authors:  Curtis A Nutter; Elizabeth Jaworski; Sunil K Verma; Yareli Perez-Carrasco; Muge N Kuyumcu-Martinez
Journal:  Muscle Nerve       Date:  2017-04-17       Impact factor: 3.217

3.  Dorsal root ganglia P2X4 and P2X7 receptors contribute to diabetes-induced hyperalgesia and the downregulation of electroacupuncture on P2X4 and P2X7.

Authors:  Qun-Qi Hu; Xiao-Fen He; Yi-Qi Ma; Li-Qian Ma; Si-Ying Qu; Han-Zhi Wang; Yu-Rong Kang; Lu-Hang Chen; Xiang Li; Bo-Yu Liu; Xiao-Mei Shao; Jun-Fan Fang; Yi Liang; Jian-Qiao Fang; Yong-Liang Jiang
Journal:  Purinergic Signal       Date:  2022-02-26       Impact factor: 3.765

4.  Overcoming barriers to diabetic polyneuropathy management in primary care.

Authors:  Alyce S Adams; Brian Callaghan; Richard W Grant
Journal:  Healthc (Amst)       Date:  2016-12-07

5.  Huangqi Guizhi Wuwu Decoction for treating diabetic peripheral neuropathy: a meta-analysis of 16 randomized controlled trials.

Authors:  Bing Pang; Tian-Yu Zhao; Lin-Hua Zhao; Fang Wan; Ru Ye; Qiang Zhou; Feng Tian; Xiao-Lin Tong
Journal:  Neural Regen Res       Date:  2016-08       Impact factor: 5.135

6.  Methylglyoxal Requires AC1 and TRPA1 to Produce Pain and Spinal Neuron Activation.

Authors:  Ryan B Griggs; Don E Laird; Renee R Donahue; Weisi Fu; Bradley K Taylor
Journal:  Front Neurosci       Date:  2017-12-06       Impact factor: 4.677

7.  Diabetic neuropathy: are we still barking up the wrong tree and is change finally in sight?

Authors:  David V Coppini
Journal:  Diabetologia       Date:  2020-07-17       Impact factor: 10.122

8.  Suppressing PKC-dependent membrane P2X3 receptor upregulation in dorsal root ganglia mediated electroacupuncture analgesia in rat painful diabetic neuropathy.

Authors:  Ya-Feng Zhou; Xiao-Ming Ying; Xiao-Fen He; Sheng-Yun Shou; Jun-Jun Wei; Zhao-Xia Tai; Xiao-Mei Shao; Yi Liang; Fang Fang; Jian-Qiao Fang; Yong-Liang Jiang
Journal:  Purinergic Signal       Date:  2018-08-07       Impact factor: 3.765

9.  Efficacy and Safety of the Combination of Superoxide Dismutase, Alpha Lipoic Acid, Vitamin B12, and Carnitine for 12 Months in Patients with Diabetic Neuropathy.

Authors:  Triantafyllos Didangelos; Eleni Karlafti; Evangelia Kotzakioulafi; Zisis Kontoninas; Charalampos Margaritidis; Parthena Giannoulaki; Konstantinos Kantartzis
Journal:  Nutrients       Date:  2020-10-23       Impact factor: 5.717

10.  Electroacupuncture alleviates diabetic neuropathic pain in rats by suppressing P2X3 receptor expression in dorsal root ganglia.

Authors:  Xueyu Fei; Xiaofen He; Zhaoxia Tai; Hanzhi Wang; Siying Qu; Luhang Chen; Qunqi Hu; Jianqiao Fang; Yongliang Jiang
Journal:  Purinergic Signal       Date:  2020-10-03       Impact factor: 3.765

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.